The global economy is at a critical crossroads with a number of interlocking challenges and crises running in parallel. The uncertainty around how Russia`s war on Ukraine will play out this year and the war`s role in creating global instability means that the trouble on the inflation front is not over yet.

New York, Feb. 02, 2023 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Canine Stem Cell Therapy Industry" - https://www.reportlinker.com/p06040367/?utm_source=GNW
Food and fuel inflation will remain a persistent economic problem. Higher retail inflation will impact consumer confidence and spending. As governments combat inflation by raising interest rates, new job creation will slowdown and impact economic activity and growth. Lower capital expenditure is in the offing as companies go slow on investments, held back by inflation worries and weaker demand. With slower growth and high inflation, developed markets seem primed to enter into a recession. Fears of new COVID outbreaks and China’s already uncertain post-pandemic path poses a real risk of the world experiencing more acute supply chain pain and manufacturing disruptions this year. Volatile financial markets, growing trade tensions, stricter regulatory environment and pressure to mainstream climate change into economic decisions will compound the complexity of challenges faced. Year 2023 is expected to be tough year for most markets, investors and consumers. Nevertheless, there is always opportunity for businesses and their leaders who can chart a path forward with resilience and adaptability.

Global Canine Stem Cell Therapy Market to Reach $228.1 Million by 2030

In the changed post COVID-19 business landscape, the global market for Canine Stem Cell Therapy estimated at US$173.1 Million in the year 2022, is projected to reach a revised size of US$228.1 Million by 2030, growing at aCAGR of 3.5% over the period 2022-2030. Allogeneic Stem Cells, one of the segments analyzed in the report, is projected to record 4% CAGR and reach US$157.6 Million by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Autologous Stem Cells segment is readjusted to a revised 2.5% CAGR for the next 8-year period.

The U.S. Market is Estimated at $50.6 Million, While China is Forecast to Grow at 3.3% CAGR

The Canine Stem Cell Therapy market in the U.S. is estimated at US$50.6 Million in the year 2022. China, the world`s second largest economy, is forecast to reach a projected market size of US$40.6 Million by the year 2030 trailing a CAGR of 3.3% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 3.3% and 2.9% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 3.4% CAGR.

Select Competitors (Total 47 Featured)
- Animal Cell Therapies, Inc
- Aratana Therapeutics, Inc.
- Cell Therapy Sciences
- Magellan Stem Cells
- MediVet Biologics, LLC
- Okyanos
- Regeneus Ltd.
- Stem Cell Vet
- Vetbiologics
- VetMatrix


Read the full report: https://www.reportlinker.com/p06040367/?utm_source=GNW

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW
Influencer Market Insights
World Market Trajectories
Canine Stem Cell Therapy - Global Key Competitors Percentage
Market Share in 2022 (E)
Competitive Market Presence - Strong/Active/Niche/Trivial for
Players Worldwide in 2022 (E)
Players Worldwide in 2022 (E

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE
Table 1: World Recent Past, Current & Future Analysis for
Canine Stem Cell Therapy by Geographic Region - USA, Canada,
Japan, China, Europe, Asia-Pacific and Rest of World Markets -
Independent Analysis of Annual Sales in US$ for Years 2022
through 2030 and % CAGR

Table 2: World Historic Review for Canine Stem Cell Therapy by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ for Years 2014 through 2021 and % CAGR

Table 3: World 16-Year Perspective for Canine Stem Cell Therapy
by Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World Markets for Years 2014, 2023 & 2030

Table 4: World Recent Past, Current & Future Analysis for
Allogeneic Stem Cells by Geographic Region - USA, Canada,
Japan, China, Europe, Asia-Pacific and Rest of World Markets -
Independent Analysis of Annual Sales in US$ for Years 2022
through 2030 and % CAGR

Table 5: World Historic Review for Allogeneic Stem Cells by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ for Years 2014 through 2021 and % CAGR

Table 6: World 16-Year Perspective for Allogeneic Stem Cells by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2014, 2023 & 2030

Table 7: World Recent Past, Current & Future Analysis for
Autologous Stem Cells by Geographic Region - USA, Canada,
Japan, China, Europe, Asia-Pacific and Rest of World Markets -
Independent Analysis of Annual Sales in US$ for Years 2022
through 2030 and % CAGR

Table 8: World Historic Review for Autologous Stem Cells by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ for Years 2014 through 2021 and % CAGR

Table 9: World 16-Year Perspective for Autologous Stem Cells by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2014, 2023 & 2030

Table 10: World Recent Past, Current & Future Analysis for
Veterinary Hospitals by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific and Rest of World Markets -
Independent Analysis of Annual Sales in US$ for Years 2022
through 2030 and % CAGR

Table 11: World Historic Review for Veterinary Hospitals by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ for Years 2014 through 2021 and % CAGR

Table 12: World 16-Year Perspective for Veterinary Hospitals by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2014, 2023 & 2030

Table 13: World Recent Past, Current & Future Analysis for
Veterinary Clinics by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific and Rest of World Markets -
Independent Analysis of Annual Sales in US$ for Years 2022
through 2030 and % CAGR

Table 14: World Historic Review for Veterinary Clinics by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ for Years 2014 through 2021 and % CAGR

Table 15: World 16-Year Perspective for Veterinary Clinics by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2014, 2023 & 2030

Table 16: World Recent Past, Current & Future Analysis for
Veterinary Research Institutes by Geographic Region - USA,
Canada, Japan, China, Europe, Asia-Pacific and Rest of World
Markets - Independent Analysis of Annual Sales in US$ for Years
2022 through 2030 and % CAGR

Table 17: World Historic Review for Veterinary Research
Institutes by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets - Independent
Analysis of Annual Sales in US$ for Years 2014 through 2021 and
% CAGR

Table 18: World 16-Year Perspective for Veterinary Research
Institutes by Geographic Region - Percentage Breakdown of Value
Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and
Rest of World for Years 2014, 2023 & 2030

Table 19: World Canine Stem Cell Therapy Market Analysis of
Annual Sales in US$ for Years 2014 through 2030

III. MARKET ANALYSIS

UNITED STATES
Canine Stem Cell Therapy Market Presence - Strong/Active/Niche/
Trivial - Key Competitors in the United States for 2023 (E)
Table 20: USA Recent Past, Current & Future Analysis for Canine
Stem Cell Therapy by Type - Allogeneic Stem Cells and
Autologous Stem Cells - Independent Analysis of Annual Sales in
US$ for the Years 2022 through 2030 and % CAGR

Table 21: USA Historic Review for Canine Stem Cell Therapy by
Type - Allogeneic Stem Cells and Autologous Stem Cells Markets -
Independent Analysis of Annual Sales in US$ for Years 2014
through 2021 and % CAGR

Table 22: USA 16-Year Perspective for Canine Stem Cell Therapy
by Type - Percentage Breakdown of Value Sales for Allogeneic
Stem Cells and Autologous Stem Cells for the Years 2014, 2023 &
2030

Table 23: USA Recent Past, Current & Future Analysis for Canine
Stem Cell Therapy by End-Use - Veterinary Hospitals, Veterinary
Clinics and Veterinary Research Institutes - Independent
Analysis of Annual Sales in US$ for the Years 2022 through 2030
and % CAGR

Table 24: USA Historic Review for Canine Stem Cell Therapy by
End-Use - Veterinary Hospitals, Veterinary Clinics and
Veterinary Research Institutes Markets - Independent Analysis
of Annual Sales in US$ for Years 2014 through 2021 and % CAGR

Table 25: USA 16-Year Perspective for Canine Stem Cell Therapy
by End-Use - Percentage Breakdown of Value Sales for Veterinary
Hospitals, Veterinary Clinics and Veterinary Research
Institutes for the Years 2014, 2023 & 2030

CANADA
Table 26: Canada Recent Past, Current & Future Analysis for
Canine Stem Cell Therapy by Type - Allogeneic Stem Cells and
Autologous Stem Cells - Independent Analysis of Annual Sales in
US$ for the Years 2022 through 2030 and % CAGR

Table 27: Canada Historic Review for Canine Stem Cell Therapy
by Type - Allogeneic Stem Cells and Autologous Stem Cells
Markets - Independent Analysis of Annual Sales in US$ for Years
2014 through 2021 and % CAGR

Table 28: Canada 16-Year Perspective for Canine Stem Cell
Therapy by Type - Percentage Breakdown of Value Sales for
Allogeneic Stem Cells and Autologous Stem Cells for the Years
2014, 2023 & 2030

Table 29: Canada Recent Past, Current & Future Analysis for
Canine Stem Cell Therapy by End-Use - Veterinary Hospitals,
Veterinary Clinics and Veterinary Research Institutes -
Independent Analysis of Annual Sales in US$ for the Years 2022
through 2030 and % CAGR

Table 30: Canada Historic Review for Canine Stem Cell Therapy
by End-Use - Veterinary Hospitals, Veterinary Clinics and
Veterinary Research Institutes Markets - Independent Analysis
of Annual Sales in US$ for Years 2014 through 2021 and % CAGR

Table 31: Canada 16-Year Perspective for Canine Stem Cell
Therapy by End-Use - Percentage Breakdown of Value Sales for
Veterinary Hospitals, Veterinary Clinics and Veterinary
Research Institutes for the Years 2014, 2023 & 2030

JAPAN
Canine Stem Cell Therapy Market Presence - Strong/Active/Niche/
Trivial - Key Competitors in Japan for 2023 (E)
Table 32: Japan Recent Past, Current & Future Analysis for
Canine Stem Cell Therapy by Type - Allogeneic Stem Cells and
Autologous Stem Cells - Independent Analysis of Annual Sales in
US$ for the Years 2022 through 2030 and % CAGR

Table 33: Japan Historic Review for Canine Stem Cell Therapy by
Type - Allogeneic Stem Cells and Autologous Stem Cells Markets -
Independent Analysis of Annual Sales in US$ for Years 2014
through 2021 and % CAGR

Table 34: Japan 16-Year Perspective for Canine Stem Cell
Therapy by Type - Percentage Breakdown of Value Sales for
Allogeneic Stem Cells and Autologous Stem Cells for the Years
2014, 2023 & 2030

Table 35: Japan Recent Past, Current & Future Analysis for
Canine Stem Cell Therapy by End-Use - Veterinary Hospitals,
Veterinary Clinics and Veterinary Research Institutes -
Independent Analysis of Annual Sales in US$ for the Years 2022
through 2030 and % CAGR

Table 36: Japan Historic Review for Canine Stem Cell Therapy by
End-Use - Veterinary Hospitals, Veterinary Clinics and
Veterinary Research Institutes Markets - Independent Analysis
of Annual Sales in US$ for Years 2014 through 2021 and % CAGR

Table 37: Japan 16-Year Perspective for Canine Stem Cell
Therapy by End-Use - Percentage Breakdown of Value Sales for
Veterinary Hospitals, Veterinary Clinics and Veterinary
Research Institutes for the Years 2014, 2023 & 2030

CHINA
Canine Stem Cell Therapy Market Presence - Strong/Active/Niche/
Trivial - Key Competitors in China for 2023 (E)
Table 38: China Recent Past, Current & Future Analysis for
Canine Stem Cell Therapy by Type - Allogeneic Stem Cells and
Autologous Stem Cells - Independent Analysis of Annual Sales in
US$ for the Years 2022 through 2030 and % CAGR

Table 39: China Historic Review for Canine Stem Cell Therapy by
Type - Allogeneic Stem Cells and Autologous Stem Cells Markets -
Independent Analysis of Annual Sales in US$ for Years 2014
through 2021 and % CAGR

Table 40: China 16-Year Perspective for Canine Stem Cell
Therapy by Type - Percentage Breakdown of Value Sales for
Allogeneic Stem Cells and Autologous Stem Cells for the Years
2014, 2023 & 2030

Table 41: China Recent Past, Current & Future Analysis for
Canine Stem Cell Therapy by End-Use - Veterinary Hospitals,
Veterinary Clinics and Veterinary Research Institutes -
Independent Analysis of Annual Sales in US$ for the Years 2022
through 2030 and % CAGR

Table 42: China Historic Review for Canine Stem Cell Therapy by
End-Use - Veterinary Hospitals, Veterinary Clinics and
Veterinary Research Institutes Markets - Independent Analysis
of Annual Sales in US$ for Years 2014 through 2021 and % CAGR

Table 43: China 16-Year Perspective for Canine Stem Cell
Therapy by End-Use - Percentage Breakdown of Value Sales for
Veterinary Hospitals, Veterinary Clinics and Veterinary
Research Institutes for the Years 2014, 2023 & 2030

EUROPE
Canine Stem Cell Therapy Market Presence - Strong/Active/Niche/
Trivial - Key Competitors in Europe for 2023 (E)
Table 44: Europe Recent Past, Current & Future Analysis for
Canine Stem Cell Therapy by Geographic Region - France,
Germany, Italy, UK and Rest of Europe Markets - Independent
Analysis of Annual Sales in US$ for Years 2022 through 2030 and
% CAGR

Table 45: Europe Historic Review for Canine Stem Cell Therapy
by Geographic Region - France, Germany, Italy, UK and Rest of
Europe Markets - Independent Analysis of Annual Sales in US$
for Years 2014 through 2021 and % CAGR

Table 46: Europe 16-Year Perspective for Canine Stem Cell
Therapy by Geographic Region - Percentage Breakdown of Value
Sales for France, Germany, Italy, UK and Rest of Europe Markets
for Years 2014, 2023 & 2030

Table 47: Europe Recent Past, Current & Future Analysis for
Canine Stem Cell Therapy by Type - Allogeneic Stem Cells and
Autologous Stem Cells - Independent Analysis of Annual Sales in
US$ for the Years 2022 through 2030 and % CAGR

Table 48: Europe Historic Review for Canine Stem Cell Therapy
by Type - Allogeneic Stem Cells and Autologous Stem Cells
Markets - Independent Analysis of Annual Sales in US$ for Years
2014 through 2021 and % CAGR

Table 49: Europe 16-Year Perspective for Canine Stem Cell
Therapy by Type - Percentage Breakdown of Value Sales for
Allogeneic Stem Cells and Autologous Stem Cells for the Years
2014, 2023 & 2030

Table 50: Europe Recent Past, Current & Future Analysis for
Canine Stem Cell Therapy by End-Use - Veterinary Hospitals,
Veterinary Clinics and Veterinary Research Institutes -
Independent Analysis of Annual Sales in US$ for the Years 2022
through 2030 and % CAGR

Table 51: Europe Historic Review for Canine Stem Cell Therapy
by End-Use - Veterinary Hospitals, Veterinary Clinics and
Veterinary Research Institutes Markets - Independent Analysis
of Annual Sales in US$ for Years 2014 through 2021 and % CAGR

Table 52: Europe 16-Year Perspective for Canine Stem Cell
Therapy by End-Use - Percentage Breakdown of Value Sales for
Veterinary Hospitals, Veterinary Clinics and Veterinary
Research Institutes for the Years 2014, 2023 & 2030

FRANCE
Canine Stem Cell Therapy Market Presence - Strong/Active/Niche/
Trivial - Key Competitors in France for 2023 (E)
Table 53: France Recent Past, Current & Future Analysis for
Canine Stem Cell Therapy by Type - Allogeneic Stem Cells and
Autologous Stem Cells - Independent Analysis of Annual Sales in
US$ for the Years 2022 through 2030 and % CAGR

Table 54: France Historic Review for Canine Stem Cell Therapy
by Type - Allogeneic Stem Cells and Autologous Stem Cells
Markets - Independent Analysis of Annual Sales in US$ for Years
2014 through 2021 and % CAGR

Table 55: France 16-Year Perspective for Canine Stem Cell
Therapy by Type - Percentage Breakdown of Value Sales for
Allogeneic Stem Cells and Autologous Stem Cells for the Years
2014, 2023 & 2030

Table 56: France Recent Past, Current & Future Analysis for
Canine Stem Cell Therapy by End-Use - Veterinary Hospitals,
Veterinary Clinics and Veterinary Research Institutes -
Independent Analysis of Annual Sales in US$ for the Years 2022
through 2030 and % CAGR

Table 57: France Historic Review for Canine Stem Cell Therapy
by End-Use - Veterinary Hospitals, Veterinary Clinics and
Veterinary Research Institutes Markets - Independent Analysis
of Annual Sales in US$ for Years 2014 through 2021 and % CAGR

Table 58: France 16-Year Perspective for Canine Stem Cell
Therapy by End-Use - Percentage Breakdown of Value Sales for
Veterinary Hospitals, Veterinary Clinics and Veterinary
Research Institutes for the Years 2014, 2023 & 2030

GERMANY
Canine Stem Cell Therapy Market Presence - Strong/Active/Niche/
Trivial - Key Competitors in Germany for 2023 (E)
Table 59: Germany Recent Past, Current & Future Analysis for
Canine Stem Cell Therapy by Type - Allogeneic Stem Cells and
Autologous Stem Cells - Independent Analysis of Annual Sales in
US$ for the Years 2022 through 2030 and % CAGR

Table 60: Germany Historic Review for Canine Stem Cell Therapy
by Type - Allogeneic Stem Cells and Autologous Stem Cells
Markets - Independent Analysis of Annual Sales in US$ for Years
2014 through 2021 and % CAGR

Table 61: Germany 16-Year Perspective for Canine Stem Cell
Therapy by Type - Percentage Breakdown of Value Sales for
Allogeneic Stem Cells and Autologous Stem Cells for the Years
2014, 2023 & 2030

Table 62: Germany Recent Past, Current & Future Analysis for
Canine Stem Cell Therapy by End-Use - Veterinary Hospitals,
Veterinary Clinics and Veterinary Research Institutes -
Independent Analysis of Annual Sales in US$ for the Years 2022
through 2030 and % CAGR

Table 63: Germany Historic Review for Canine Stem Cell Therapy
by End-Use - Veterinary Hospitals, Veterinary Clinics and
Veterinary Research Institutes Markets - Independent Analysis
of Annual Sales in US$ for Years 2014 through 2021 and % CAGR

Table 64: Germany 16-Year Perspective for Canine Stem Cell
Therapy by End-Use - Percentage Breakdown of Value Sales for
Veterinary Hospitals, Veterinary Clinics and Veterinary
Research Institutes for the Years 2014, 2023 & 2030

ITALY
Table 65: Italy Recent Past, Current & Future Analysis for
Canine Stem Cell Therapy by Type - Allogeneic Stem Cells and
Autologous Stem Cells - Independent Analysis of Annual Sales in
US$ for the Years 2022 through 2030 and % CAGR

Table 66: Italy Historic Review for Canine Stem Cell Therapy by
Type - Allogeneic Stem Cells and Autologous Stem Cells Markets -
Independent Analysis of Annual Sales in US$ for Years 2014
through 2021 and % CAGR

Table 67: Italy 16-Year Perspective for Canine Stem Cell
Therapy by Type - Percentage Breakdown of Value Sales for
Allogeneic Stem Cells and Autologous Stem Cells for the Years
2014, 2023 & 2030

Table 68: Italy Recent Past, Current & Future Analysis for
Canine Stem Cell Therapy by End-Use - Veterinary Hospitals,
Veterinary Clinics and Veterinary Research Institutes -
Independent Analysis of Annual Sales in US$ for the Years 2022
through 2030 and % CAGR

Table 69: Italy Historic Review for Canine Stem Cell Therapy by
End-Use - Veterinary Hospitals, Veterinary Clinics and
Veterinary Research Institutes Markets - Independent Analysis
of Annual Sales in US$ for Years 2014 through 2021 and % CAGR

Table 70: Italy 16-Year Perspective for Canine Stem Cell
Therapy by End-Use - Percentage Breakdown of Value Sales for
Veterinary Hospitals, Veterinary Clinics and Veterinary
Research Institutes for the Years 2014, 2023 & 2030

UNITED KINGDOM
Canine Stem Cell Therapy Market Presence - Strong/Active/Niche/
Trivial - Key Competitors in the United Kingdom for 2023 (E)
Table 71: UK Recent Past, Current & Future Analysis for Canine
Stem Cell Therapy by Type - Allogeneic Stem Cells and
Autologous Stem Cells - Independent Analysis of Annual Sales in
US$ for the Years 2022 through 2030 and % CAGR

Table 72: UK Historic Review for Canine Stem Cell Therapy by
Type - Allogeneic Stem Cells and Autologous Stem Cells Markets -
Independent Analysis of Annual Sales in US$ for Years 2014
through 2021 and % CAGR

Table 73: UK 16-Year Perspective for Canine Stem Cell Therapy
by Type - Percentage Breakdown of Value Sales for Allogeneic
Stem Cells and Autologous Stem Cells for the Years 2014, 2023 &
2030

Table 74: UK Recent Past, Current & Future Analysis for Canine
Stem Cell Therapy by End-Use - Veterinary Hospitals, Veterinary
Clinics and Veterinary Research Institutes - Independent
Analysis of Annual Sales in US$ for the Years 2022 through 2030
and % CAGR

Table 75: UK Historic Review for Canine Stem Cell Therapy by
End-Use - Veterinary Hospitals, Veterinary Clinics and
Veterinary Research Institutes Markets - Independent Analysis
of Annual Sales in US$ for Years 2014 through 2021 and % CAGR

Table 76: UK 16-Year Perspective for Canine Stem Cell Therapy
by End-Use - Percentage Breakdown of Value Sales for Veterinary
Hospitals, Veterinary Clinics and Veterinary Research
Institutes for the Years 2014, 2023 & 2030

REST OF EUROPE
Table 77: Rest of Europe Recent Past, Current & Future Analysis
for Canine Stem Cell Therapy by Type - Allogeneic Stem Cells
and Autologous Stem Cells - Independent Analysis of Annual
Sales in US$ for the Years 2022 through 2030 and % CAGR

Table 78: Rest of Europe Historic Review for Canine Stem Cell
Therapy by Type - Allogeneic Stem Cells and Autologous Stem
Cells Markets - Independent Analysis of Annual Sales in US$ for
Years 2014 through 2021 and % CAGR

Table 79: Rest of Europe 16-Year Perspective for Canine Stem
Cell Therapy by Type - Percentage Breakdown of Value Sales for
Allogeneic Stem Cells and Autologous Stem Cells for the Years
2014, 2023 & 2030

Table 80: Rest of Europe Recent Past, Current & Future Analysis
for Canine Stem Cell Therapy by End-Use - Veterinary Hospitals,
Veterinary Clinics and Veterinary Research Institutes -
Independent Analysis of Annual Sales in US$ for the Years 2022
through 2030 and % CAGR

Table 81: Rest of Europe Historic Review for Canine Stem Cell
Therapy by End-Use - Veterinary Hospitals, Veterinary Clinics
and Veterinary Research Institutes Markets - Independent
Analysis of Annual Sales in US$ for Years 2014 through 2021 and
% CAGR

Table 82: Rest of Europe 16-Year Perspective for Canine Stem
Cell Therapy by End-Use - Percentage Breakdown of Value Sales
for Veterinary Hospitals, Veterinary Clinics and Veterinary
Research Institutes for the Years 2014, 2023 & 2030

ASIA-PACIFIC
Canine Stem Cell Therapy Market Presence - Strong/Active/Niche/
Trivial - Key Competitors in Asia-Pacific for 2023 (E)
Table 83: Asia-Pacific Recent Past, Current & Future Analysis
for Canine Stem Cell Therapy by Type - Allogeneic Stem Cells
and Autologous Stem Cells - Independent Analysis of Annual
Sales in US$ for the Years 2022 through 2030 and % CAGR

Table 84: Asia-Pacific Historic Review for Canine Stem Cell
Therapy by Type - Allogeneic Stem Cells and Autologous Stem
Cells Markets - Independent Analysis of Annual Sales in US$ for
Years 2014 through 2021 and % CAGR

Table 85: Asia-Pacific 16-Year Perspective for Canine Stem Cell
Therapy by Type - Percentage Breakdown of Value Sales for
Allogeneic Stem Cells and Autologous Stem Cells for the Years
2014, 2023 & 2030

Table 86: Asia-Pacific Recent Past, Current & Future Analysis
for Canine Stem Cell Therapy by End-Use - Veterinary Hospitals,
Veterinary Clinics and Veterinary Research Institutes -
Independent Analysis of Annual Sales in US$ for the Years 2022
through 2030 and % CAGR

Table 87: Asia-Pacific Historic Review for Canine Stem Cell
Therapy by End-Use - Veterinary Hospitals, Veterinary Clinics
and Veterinary Research Institutes Markets - Independent
Analysis of Annual Sales in US$ for Years 2014 through 2021 and
% CAGR

Table 88: Asia-Pacific 16-Year Perspective for Canine Stem Cell
Therapy by End-Use - Percentage Breakdown of Value Sales for
Veterinary Hospitals, Veterinary Clinics and Veterinary
Research Institutes for the Years 2014, 2023 & 2030

REST OF WORLD
Table 89: Rest of World Recent Past, Current & Future Analysis
for Canine Stem Cell Therapy by Type - Allogeneic Stem Cells
and Autologous Stem Cells - Independent Analysis of Annual
Sales in US$ for the Years 2022 through 2030 and % CAGR

Table 90: Rest of World Historic Review for Canine Stem Cell
Therapy by Type - Allogeneic Stem Cells and Autologous Stem
Cells Markets - Independent Analysis of Annual Sales in US$ for
Years 2014 through 2021 and % CAGR

Table 91: Rest of World 16-Year Perspective for Canine Stem
Cell Therapy by Type - Percentage Breakdown of Value Sales for
Allogeneic Stem Cells and Autologous Stem Cells for the Years
2014, 2023 & 2030

Table 92: Rest of World Recent Past, Current & Future Analysis
for Canine Stem Cell Therapy by End-Use - Veterinary Hospitals,
Veterinary Clinics and Veterinary Research Institutes -
Independent Analysis of Annual Sales in US$ for the Years 2022
through 2030 and % CAGR

Table 93: Rest of World Historic Review for Canine Stem Cell
Therapy by End-Use - Veterinary Hospitals, Veterinary Clinics
and Veterinary Research Institutes Markets - Independent
Analysis of Annual Sales in US$ for Years 2014 through 2021 and
% CAGR

Table 94: Rest of World 16-Year Perspective for Canine Stem
Cell Therapy by End-Use - Percentage Breakdown of Value Sales
for Veterinary Hospitals, Veterinary Clinics and Veterinary
Research Institutes for the Years 2014, 2023 & 2030

IV. COMPETITION
Read the full report: https://www.reportlinker.com/p06040367/?utm_source=GNW

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________

CONTACT: Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001